513 related articles for article (PubMed ID: 17727269)
1. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
[TBL] [Abstract][Full Text] [Related]
2. Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands.
Marchetti F; Pettinari C; Cerquetella A; Cingolani A; Pettinari R; Monari M; Wanke R; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2009 Jul; 48(13):6096-108. PubMed ID: 19507885
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
[TBL] [Abstract][Full Text] [Related]
4. 3,6-bis(2'-pyridyl)pyridazine (L) and its deprotonated form (L - H+)- as ligands for {(acac)2Ru(n+)} or {(bpy)2Ru(m+)}: investigation of mixed valency in [{(acac)2Ru}2(mu-L - H+)]0 and [{(bpy)2Ru}2(mu-L - H+)]4+ by spectroelectrochemistry and EPR.
Ghumaan S; Sarkar B; Patra S; Parimal K; van Slageren J; Fiedler J; Kaim W; Lahiri GK
Dalton Trans; 2005 Feb; (4):706-12. PubMed ID: 15702181
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure, redox, NLO and DNA interaction aspects of [((L'-'")2RuII)3(mu3-L)]3+ and [(L')2RuII(NC5H4S-)]+[L3- = 1,3,5-triazine-2,4,6-trithiolato, L'-'" = arylazopyridine].
Kar S; Pradhan B; Sinha RK; Kundu T; Kodgire P; Rao KK; Puranik VG; Lahiri GK
Dalton Trans; 2004 Jun; (11):1752-60. PubMed ID: 15252573
[TBL] [Abstract][Full Text] [Related]
6. Mixed-valent metals bridged by a radical ligand: fact or fiction based on structure-oxidation state correlations.
Sarkar B; Patra S; Fiedler J; Sunoj RB; Janardanan D; Lahiri GK; Kaim W
J Am Chem Soc; 2008 Mar; 130(11):3532-42. PubMed ID: 18290644
[TBL] [Abstract][Full Text] [Related]
7. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
[TBL] [Abstract][Full Text] [Related]
8. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure of cycloruthenated carbonyl complexes and their emission, redox and biological properties.
Naresh Kumar K; Ramesh R; Liu Y
J Inorg Biochem; 2006 Jan; 100(1):18-26. PubMed ID: 16310253
[TBL] [Abstract][Full Text] [Related]
10. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
Yadav M; Singh AK; Maiti B; Pandey DS
Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
[TBL] [Abstract][Full Text] [Related]
11. Diorganoruthenium complexes incorporating noninnocent [C(6)H(2)(CH(2)ER(2))(2)-3,5](2)(2-) (E = N, P) bis-pincer bridging ligands: synthesis, spectroelectrochemistry, and DFT studies.
Gagliardo M; Amijs CH; Lutz M; Spek AL; Havenith RW; Hartl F; van Klink GP; van Koten G
Inorg Chem; 2007 Dec; 46(26):11133-44. PubMed ID: 18052055
[TBL] [Abstract][Full Text] [Related]
12. Substitution reactions in dinuclear Ru-Hbpp complexes: an evaluation of through-space interactions.
Planas N; Christian G; Roeser S; Mas-Marzá E; Kollipara MR; Benet-Buchholz J; Maseras F; Llobet A
Inorg Chem; 2012 Feb; 51(3):1889-901. PubMed ID: 22242940
[TBL] [Abstract][Full Text] [Related]
13. Valence-state analysis through spectroelectrochemistry in a series of quinonoid-bridged diruthenium complexes [(acac)(2)Ru(mu-L)Ru(acac)(2)](n) (n=+2, +1, 0, -1, -2).
Ghumaan S; Sarkar B; Maji S; Puranik VG; Fiedler J; Urbanos FA; Jimenez-Aparicio R; Kaim W; Lahiri GK
Chemistry; 2008; 14(34):10816-28. PubMed ID: 18924186
[TBL] [Abstract][Full Text] [Related]
14. A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2.
Caspar R; Cordier C; Waern JB; Guyard-Duhayon C; Gruselle M; Le Floch P; Amouri H
Inorg Chem; 2006 May; 45(10):4071-8. PubMed ID: 16676968
[TBL] [Abstract][Full Text] [Related]
15. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
[TBL] [Abstract][Full Text] [Related]
17. Hydrocarbon oxidation by beta-halogenated dioxoruthenium(VI) porphyrin complexes: effect of reduction potential (RuVI/V) and C-H bond-dissociation energy on rate constants.
Che CM; Zhang JL; Zhang R; Huang JS; Lai TS; Tsui WM; Zhou XG; Zhou ZY; Zhu N; Chang CK
Chemistry; 2005 Nov; 11(23):7040-53. PubMed ID: 16163758
[TBL] [Abstract][Full Text] [Related]
18. One-pot synthesis of symmetric and asymmetric p-quinone ligands and unprecedented substituent induced reactivity in their dinuclear ruthenium complexes.
Schweinfurth D; Das HS; Weisser F; Bubrin D; Sarkar B
Inorg Chem; 2011 Feb; 50(3):1150-9. PubMed ID: 21214266
[TBL] [Abstract][Full Text] [Related]
19. Trivalent iron and ruthenium complexes with a redox noninnocent (2-mercaptophenylimino)-methyl-4,6-di-tert-butylphenolate(2-) ligand.
Roy N; Sproules S; Weyhermüller T; Wieghardt K
Inorg Chem; 2009 Apr; 48(8):3783-91. PubMed ID: 19361249
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
